HYMMN v1.0

  • Research type

    Research Study

  • Full title

    The HYsteroscopic Miscarriage MaNagement (HYMMN) Trial

  • IRAS ID

    276909

  • Contact name

    Prathiba De Silva

  • Contact email

    prathiba.desilva@nhs.net

  • Sponsor organisation

    Birmingham Women's and Children's NHS Foundation Trust

  • Duration of Study in the UK

    1 years, 10 months, 12 days

  • Research summary

    1 in 4 pregnancies unfortunately ends in a miscarriage which is the failure of pregnancy before 24 weeks gestation. Women can be offered expectant management (giving time for the pregnancy to pass by itself), medical management (involving medications which cause the womb to contract to expel the pregnancy sooner) or surgical management (involving the ‘blind’ use of a suction tube passed into the womb, often under a general anaesthetic).

    Retained products of conception (RPOC) are found in up to 20% of women following a miscarriage. The above treatment options used to manage miscarriage are also offered for RPOC, however, because there is no evidence on how well they work, symptoms such as bleeding and pain can be prolonged. This requires further hospital visits and inpatient admissions, thus causing significant physiological and psychological stress to women and their partners as well as the additional use of healthcare resources. Fertility can be delayed, or worse, permanently impaired, because of damage and scarring of the womb lining due to either chronic inflammation from the RPOC themselves or from mechanical trauma following surgical management.

    Observational studies show that performing hysteroscopy (a small telescope already being used to diagnose and treat conditions affecting womb lining in the outpatient setting) to remove RPOC may be associated with higher rates of uterine evacuation and less time to the next pregnancy.

    We therefore propose a pilot randomised controlled trial that involves the routine use of ultrasound scanning for RPOC and randomisation of affected women to either have hysteroscopy or current treatment (expectant, medical, surgical management), allowing for comparison of pregnancy rates, bleeding, quality of life and healthcare resource use. Performing this pilot study prior to the main study can avoid trials that will fail and increase the likelihood of success of the main study.

  • REC name

    West Midlands - Solihull Research Ethics Committee

  • REC reference

    20/WM/0287

  • Date of REC Opinion

    18 Dec 2020

  • REC opinion

    Further Information Favourable Opinion